Skip to content

LYCA LYCIA THERAPEUTICS INC

Follow

Common Stock, $0.0001 par value per share (common), issuer CIK 1806540

No 13F filer reports this security in the loaded quarters.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

Events

  • Venrock Healthcare Capital Partners III, L.P. and 8 other reporting persons reported 6,850,237 LYCA shares, 11.9% of the class, as of 2026-10-23, in a 13G filed 2026-10-30. 0001738048-26-000077

    Accepted , ingested